Deferred Income Tax Expense (Benefit) of IOVANCE BIOTHERAPEUTICS, INC. from 31 Mar 2023 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
IOVANCE BIOTHERAPEUTICS, INC. annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2023 to 31 Dec 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $1,838,000, a 31% decline year-over-year.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Deferred Income Tax Expense (Benefit) for 2025 was $2,071,000, a 27% increase from 2024.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Deferred Income Tax Expense (Benefit) for 2024 was $2,828,000, a 19% increase from 2023.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,071,000 +$757,000 +27% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $2,828,000 +$651,000 +19% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $3,479,000 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,838,000 -$430,000 -31% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $1,408,000 -$1,408,000 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $0 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.